Vision, Inc. ( Japan) 9416
TSE · Japan · Communications
¥1,051.00-9.00 (-0.85%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
WEST FARGO, N.D., September 21, 2026--GreenMan Vision, Inc. today announced the publication of a peer-reviewed, multi-center study evaluating InSightVR, a patient-specific VR platform that helps cataract patients experience simulated vision with different intraocular lens (IOL) options before cataract surgery. The retrospective, non-randomized, multi-center analysis of 609 patients found that use of InSightVR was associated with greater selection of advanced-technology IOLs (ATIOLs), improved pa
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Vision USA Corp., which provides the Global WiFi and World eSIM connectivity solutions, a wholly owned subsidiary of Tokyo-based Vision Inc., today launched an integration with Concur® Expense. This feature will allow corporate travelers to automatically sync their global data communication expenses directly into their Concur® Expense reports, eliminating the manual tracking of receipts and streamlining the entire travel and expense (T&E) workflow. As
TOKYO & COLUMBUS, Ohio, July 21, 2026--Restore Vision, Inc. ("Restore Vision"), a clinical-stage biotechnology company advancing gene therapies for retinal disorders, and Forge Biologics ("Forge"), a leading manufacturer of gene therapies and member of Ajinomoto Bio-Pharma Services, today announced a development and manufacturing partnership to support RV-001, Restore Vision’s investigational GPCR-based optogenetic AAV gene therapy for patients with retinitis pigmentosa.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.